TECHNOLOGY / R&D ROADMAP
Growing evidence and traction
ANNAIDA is developing solid evidence on micro-MRS technology and EmbryoSpin. The safety and effectiveness of our technology has been shown in animal models. We are now initiating a multi-center study on the effectiveness and safety of EmbryoSpin in the screening and selection of human embryos. The renowned CPMA human fertility clinic in Lausanne, Switzerland, has already started patient recruitment for human oocytes donation to test the Embryospin.
TECHNOLOGY / MICRO MRS (MAGNETIC RESONANCE SPECTROSCOPY)